FREDERICK SARPONG: Open Payments
NPI 1891140638 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 23 payments from 9 companies in 2025. Trend: 2023 $518 · 2024 $177 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $232 |
| ABBVIE INC. | 3 | $141 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| Dexcom, Inc. | 2 | $59 |
| PFIZER INC. | 3 | $51 |
| Corcept Therapeutics | 1 | $21 |
| Medtronic, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: Kerendia, QULIPTA, INGREZZA, Dexcom G6 Transmitter, NURTEC ODT, Korlym, MINIMED 780G, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
